Thoughts on COVID-19 and autoimmune diseases.
Lupus Sci Med. 2020;7(1):e000396
Authors: Askanase AD, Khalili L, Buyon JP
Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia.
PMID: 32341791 [PubMed - indexed for MEDLINE]